TY - JOUR T1 - Transüretral Prostat Rezeksiyonu Sonrası Medikal Tedaviye Devam Durumunun Öngörülmesinde Preoperatif Prostat Boyutu Belirleyici midir? TT - Does Preoperative Prostate Volume Predictive For Medical Therapy Continuation After Transurethral Prostate Resection? AU - Zor, Murat PY - 2018 DA - May Y2 - 2017 DO - 10.5505/ptd.2017.24865 JF - Pamukkale Medical Journal JO - Pam Tıp Derg PB - Pamukkale University WT - DergiPark SN - 1308-0865 SP - 131 EP - 135 VL - 11 IS - 2 LA - tr AB - GİRİŞ ve AMAÇ: Benign prostat hiperplazisi (BPH) nedeniyle TURP uygulananhastaların küçük de olsa bir bölümünde postoperatif alt üriner sistemsemptomları (AÜSS) devam etmekte ve bu hastalarda medikal tedaviye devamedilmektedir. Biz de çalışmamızda, TURP uygulanan hastalarda prostat boyutu ilepostoperatif ek girişim oranları ve AÜSS nedeniyle medikal tedaviye devamedilme oranları arasında ilişki olup olmadığını araştırdık. YÖNTEM ve GEREÇLER: Preoperatif prostat boyutlarına göre hastalar Grup 1(prostat hacmi ≥80 ml) ve Grup 2 (prostat hacmi <80 ml) olarak iki grubaayrıldı. Gruplar; preoperatif PSA değerleri ve prostat volümü, eşlik edenko-morbiditeler, postoperatif ek sistoskopi ve sistometri yapılıp yapılmadığı,postoperatif medikal tedavi kullanımı açısından karşılaştırıldı.BULGULAR: Çalışmaya toplam 87 hasta dahil edildi. Grup 1’deki 26 hastadaprostat boyutu ≥80 ml iken, grup 2’deki 61 hastada prostat boyutu <80 mlidi. 87 hastanın 19’una (%22), postoperatif dönemde AÜSS’nin devam etmesinedeniyle, sistoskopi veya sistometri yapıldı ya da medikal tedavi yenidenbaşlandı. İstatistiksel olarak anlamlı olmasa da, 80 ml altında prostat hacmiolup, TURP uygulanan hastalarda, postoperatif AÜSS’nin daha sık görüldüğügözlendi. TARTIŞMA ve SONUÇ: Her ne kadar TURP sonrası işeme bozukluklarını ve riskfaktörlerini belirlemek için prospektif ve geniş serili çalışmalara ihtiyaçolsa da, elde ettiğimiz veriler büyük prostatlarda TURP’nin cerrahisonuçlarının daha yüz güldürücü olabileceğine işaret etmektedir.Türkçe Kısa Başlık: Prostat Hacmi ve Tedaviye Devam Durumu KW - TURP KW - Alt üriner sistem semptomları (AÜSS) KW - prostat boyutu KW - sistoskopi KW - sistometri N2 - INTRODUCTION: A small proportion of patients who underwent TURP for benignprostate hyperplasia suffer from persistent lower urinary tract symptoms andneeds continuing medical treatment. In our study, we aimed to evaluate whetheror not is there any relationship between preoperative prostate volume andpostoperative persistent LUTS and medical treatment continuation. METHODS: The patients were divided into two groups (group 1: prostate volume≥80 ml, and group 2: prostate volume <80 ml) according to prostate volume.Preoperative PSA levels, prostate volume, comorbidities, the necessity ofpostoperative cystoscopy and cystometry and postoperative medical therapycontinuation were evaluated and compared between groups.RESULTS: A total of 87 patients included to the study. Prostate volume was ≥80ml in 26 patients (group1), and <80 ml in 61 patients (Group 2). Of 87patients 19 (22%) had persistent LUTS and underwent cystoscopy, cystometry orwere restarted medical therapy. Despite there were no statistical significance,LUTS were seen more frequently in patients who had prostate volume less than 80ml. DISCUSSION AND CONCLUSION: Despite high volume and prospective studies arewarranted for determining the risk factors for postoperative LUTS followingTURP operations, our study demonstrates that TURP operations may have betteroutcomes in larger prostates. İngilizce Kısa Başlık: Prostate Volume and Therapy Continuation CR - 1. Abrams P, Chpple C, Khoury S, Roehrborn C, de La Rosette J. International scientific committee. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol 2009; 81: 1779-1787. CR - 2. S. Gravas, T. Bach, A. Bachmann, et al. EAU 2015 guidelines on the management of non-neurogenic male lower urinary tract tymptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). CR - 3. Reich O, Gratzke C, Stief CG. Techniques and long-term results of surgical procedures for BPH. Eur Urol 2006;49(6):970-978. CR - 4. Joshi HN, De Jong IJ, Karmacharya RM, Shrestha B, Shrestha R. Outcomes of transurethral resection of the prostate in benign prostatic hyperplasia comparing prostate size of more than 80 grams to prostate size less than 80 grams. Kathmandu Univ Med J 2014;12(47):163-167. CR - 5. Han HH, Ko WJ, Yoo TK, et al. Factors associated with continuing medical therapy after transurethral resection of prostate. Urology 2014;84(3):675-680. CR - 6. Park HK, Paick SH, Lho YS, Jun KK, Kim HG. Effect of the ratio of resected tissue in comparison with the prostate transitional zone volume on voiding function improvement after transurethral resection of prostate. Urology 2012;79(1):202-206. CR - 7. Bruskewitz RC, Larsen EH, Madsen PO, Dørflinger T. 3-year follow up of urinary symptoms after transurethral resection of the prostate. J Urol 1986;136(3):613-615. CR - 8. Kakizaki H, Machino R, Koyanagi T. Clinical experience in lower urinary tract symptoms. BJU Int 2001;88:23-26. CR - 9. Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol 2005;174:1887-1891. CR - 10. Hakenberg OW, Pinnock CB, Marshall VR. Preoperative urodynamic and symptom evaluation of patients undergoing transurethral prostatectomy: analysis of variables relevant for outcome. BJU Int. 2003;91(4):375-9. CR - 11. Seaman EK, Jacobs BZ, Blaivas JG, Kaplan SA. Persistence or recurrence of symptoms after transurethral resection of the prostate: a urodynamic assessment. J Urol. 1994;152(3):935-7. CR - 12. Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS, Lin YS, Chen CL, Tsui KH. Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide Population-Based Cohort Study. Clin Interv Aging. 2017;12:535-541. CR - 13. Ransmayr GN1, Holliger S, Schletterer K, Heidler H, Deibl M, Poewe W, Madersbacher H, Kiss G. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease. Neurology. 200822;70(4):299-303. CR - 14. Ellenberg MAX. Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 1980;92:321-323. CR - 15. Yoshimura N, Chancellor MB, Andersson K, et al. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 2005;95:733-738. CR - 16. Kaplan SA. Re: Factors Associated with Continuing Medical Therapy after Transurethral Resection of Prostate. J Urol. 2015;194(2):482. CR - 17. Oelke M, Baard J, Wijkstra H, et al. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol. 2008;54:419-426 UR - https://doi.org/10.5505/ptd.2017.24865 L1 - https://dergipark.org.tr/en/download/article-file/432442 ER -